Arlene J. Morales

No ORCID on file · 7 papers in corpus
nonrandomized-trial 1998
Fertility and sterility ·doi:10.1016/s0015-0282(98)00087-9

OBJECTIVE: To evaluate for the presence of oxidatively modified lipid-protein complexes in endometriosis and endometrium of women with endometriosis and controls. DESIGN: Controlled clinical study. SETTING: Academic tertiary care center. …

other 1998
The Journal of clinical endocrinology and metabolism ·doi:10.1210/jcem.83.6.4823

Inflammatory processes have been hypothesized to mediate some of the clinical sequelae associated with endometriosis. The peritoneal fluid (PF) of women with endometriosis is known to contain more inflammatory cells and their associated cyt…

nonrandomized-trial 1998
Fertility and sterility ·doi:10.1016/s0015-0282(98)00088-0

OBJECTIVE: To determine whether cultured human peritoneal macrophages have functional scavenger receptor(s) and whether activation of macrophages in endometriosis may involve an increase in scavenger receptor activity. DESIGN: A controlled…

review 1996
Clinical Obstetrics and Gynecology ·doi:10.1097/00003081-199606000-00018

RU-486, the first clinically available antiprogestin, has numerous gynecologic applications beyond first-trimester pregnancy termination. Long-term administration of 2 mg/day of RU-486 suppresses ovulation while maintaining serum estrogen l…

nonrandomized-trial 1995
Fertility and sterility ·doi:10.1016/s0015-0282(16)57478-0

OBJECTIVE: To examine endometrial response to long-term low-does RU486 administration. DESIGN: Retrospective controlled study of women with endometriosis treated for 6 months with 50 mg RU486 daily for 6 months. Controls consisted of women…

nonrandomized-trial 1994
Human Reproduction ·doi:10.1093/humrep/9.suppl_1.116

To evaluate the long-term effects of treatment with RU486 and to test its efficacy in endometriosis, a 3-month trial was conducted to evaluate the effects of daily administration (100 mg/day or approximately 2 mg/kg/day) on the functional a…

nonrandomized-trial 1993
·doi:10.1097/00006254-199309000-00021

Uterine leiomyomata are steroid hormone-dependent tumors that are common in reproductive-age women. Some series have found leiomyomata in up to 20 per cent of women over 30 years of age. These tumors represent the most frequent indication f…